Safety of IGIV therapy and infusion-related adverse events-Reference-Cited by-同舟云学术

Safety of IGIV therapy and infusion-related adverse events

Published:2007-05-26 Issue:1-3 Volume:38 Page:122-132
ISSN:0257-277X
Container-title:Immunologic Research
language:en
Short-container-title:Immunol Res

Author:

Ballow Mark

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1007/s12026-007-0003-5.pdf

Reference34 articles.

1. Brennan VM, Salome-Bentley NJ, Chapel HM. Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin. Clin Exp Immunol 2003;133:247–51

2. Burks A, Sampson H, Buckley R. Anaphylactic reactions after gammaglobulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N Engl J Med 1986;314:560

3. Cunningham-Rundles C, Zhou Z, Mankarious S, Courter S. Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies. J Clin Immunol 1993;13:272–8

4. de Albuquerque Campos R, Sato MN, da Silva Duarte AJ. IgG Anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy. J Clin Immunol 2000;20:77–82

5. Anonymous. Renal insufficiency and failure associated with immune globulin intravenous therapy—United States, 1985–1998. MMWR Morb Mortal Wkly Rep 1999;48:518–21

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MIS-C Treatment: Is glucocorticoid monotherapy enough for mild cases?;The American Journal of Emergency Medicine;2024-09

2. EFFECT OF AMINO ACID ADDITION AS STABILIZERS ON TOTAL PROTEIN CONTENT OF INTRAVENOUS THERAPEUTIC HUMAN NORMAL IMMUNOGLOBULIN;Asian Journal of Pharmaceutical and Clinical Research;2024-07-07

3. Effect of intravenous immunoglobulin on mortality in hospitalized patients with COVID‐19: A systematic review and meta‐analysis of randomized controlled trials;Health Science Reports;2024-07

4. Subcutaneous Immunoglobulin (SCig) for Maintenance Therapy in Severe POTS: A Case Report.;Translation: The University of Toledo Journal of Medical Sciences;2023-12-15

5. Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia;Case Reports in Dermatology;2023-10-16